Ligand validation:5VRA

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 5VRA designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5VRA_OLC_A_2407	15%	55%	0.274	0.855	0.75	0.96	1	1	3	0	88%	0.88
5VRA_OLC_A_2411	9%	49%	0.262	0.812	0.85	1.12	1	1	1	0	64%	0.64
5VRA_OLC_A_2410	7%	48%	0.267	0.781	0.85	1.17	1	1	1	0	68%	0.68
5VRA_OLC_A_2409	4%	53%	0.305	0.753	0.88	0.95	1	1	0	0	60%	0.6
5VRA_OLC_A_2408	4%	54%	0.318	0.71	0.74	1.01	1	1	0	0	84%	0.84
5VRA_OLC_A_2406	3%	50%	0.433	0.821	0.84	1.08	1	1	1	0	64%	0.64
5K2B_OLC_A_1220	35%	40%	0.134	0.899	1.25	1.13	1	1	0	0	56%	0.56
5K2C_OLC_A_1213	33%	46%	0.149	0.876	1.09	1.03	1	1	1	0	72%	0.72
4EIY_OLC_A_2427	32%	43%	0.143	0.878	1.03	1.24	1	2	0	0	64%	0.64
5K2D_OLC_A_1220	28%	40%	0.181	0.913	1.21	1.2	1	1	0	0	56%	0.56
5K2A_OLC_A_1211	24%	39%	0.193	0.908	1.28	1.19	1	1	0	0	52%	0.52
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	62%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	58%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	55%	0.146	0.929	0.68	1.06	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.